Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
437
-
Total 13F shares, excl. options
-
54.4M
-
Shares change
-
+290K
-
Total reported value, excl. options
-
$7.7B
-
Value change
-
+$8.98M
-
Put/Call ratio
-
0.87
-
Number of buys
-
218
-
Number of sells
-
-211
-
Price
-
$141.46
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2023
521 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q2 2023.
REPLIGEN CORP - COMMON STOCK (RGEN) has 437 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.4M shares
of 56.2M outstanding shares and own 96.78% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.79M shares), VANGUARD GROUP INC (5.06M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.72M shares), FMR LLC (2.47M shares), STATE STREET CORP (1.65M shares), SANDS CAPITAL MANAGEMENT, LLC (1.59M shares), BROWN CAPITAL MANAGEMENT LLC (1.45M shares), Artisan Partners Limited Partnership (1.4M shares), WELLINGTON MANAGEMENT GROUP LLP (1.37M shares), and AMERIPRISE FINANCIAL INC (1.27M shares).
This table shows the top 437 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.